Liminatus Pharma Inc Cl A (LIMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 338 | 56 |
| Receivables | N/A | 3,669 |
| Other current assets | 0 | 1,401 |
| TOTAL | $501 | $5,282 |
| Non-Current Assets | ||
| PPE Net | 12 | 1 |
| Other Non-Current Assets | 0 | 126 |
| TOTAL | $12 | $127 |
| Total Assets | $513 | $5,409 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 1,443 | 19,973 |
| Accounts payable and accrued liabilities | 8,152 | 3,461 |
| Accrued Expenses | 204 | 955 |
| Other current liabilities | 500 | N/A |
| TOTAL | $10,298 | $24,749 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 29 | 0 |
| TOTAL | $29 | $N/A |
| Total Liabilities | $10,328 | $24,749 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 44,878 | N/A |
| Common Shares | 3 | 2 |
| Retained earnings | -38,872 | -28,665 |
| TOTAL | $-9,815 | $-19,340 |
| Total Liabilities And Equity | $513 | $5,409 |